2019
DOI: 10.1016/j.phymed.2018.01.018
|View full text |Cite
|
Sign up to set email alerts
|

A strategy for the discovery and validation of toxicity quality marker of Chinese medicine based on network toxicology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(14 citation statements)
references
References 26 publications
0
14
0
Order By: Relevance
“…In terms of quality control, the information about the cultivation environment, cultivars, processing, transportation, storage time, and quantitative studies of the index components are scarcely in the existing studies. It is worth noting that the dual quality control, chemical benchmark and effect benchmark has been generally accepted (Li et al, 2019;Zhu et al, 2019). Therefore, the quality standard of it could be supported by the effect benchmark.…”
Section: Conclusion and Perspectivementioning
confidence: 99%
“…In terms of quality control, the information about the cultivation environment, cultivars, processing, transportation, storage time, and quantitative studies of the index components are scarcely in the existing studies. It is worth noting that the dual quality control, chemical benchmark and effect benchmark has been generally accepted (Li et al, 2019;Zhu et al, 2019). Therefore, the quality standard of it could be supported by the effect benchmark.…”
Section: Conclusion and Perspectivementioning
confidence: 99%
“…18 Compared with the traditional toxicological methods, which are time-consuming and less comprehensively researched, the network toxicology illustrates the interaction between compounds and the body from the overall perspective of biological networks, and explains the mechanisms of the adverse reactions of compounds. 18 However, the current network toxicology only considers molecular targets without mentioning the occurrence and development of diseases, so it lacks the systematic characteristics of disease development. 19−22 Given the incompleteness of the interactome and the limited knowledge of hepatotoxicity disease-associated genes, it is not obvious if the available data has sufficient coverage to map out modules associated with liver injury disease.…”
Section: Introductionmentioning
confidence: 99%
“…The two most commonly processed forms of PAR in clinical applications are wine‐baked Paeoniae Alba Radix (WPAR) and vinegar‐baked Paeoniae Alba Radix (VPAR). According to some studies (Li et al, ), the acidity and coldness are reduced in WPAR, and it is especially useful for postpartum abdominal pain. VPAR exhibits a greater potential activity of relieving depressed liver effects.…”
Section: Introductionmentioning
confidence: 99%
“…VPAR exhibits a greater potential activity of relieving depressed liver effects. The clinical efficacies of the RPAR and two processed products are different, which may be due to differences in the contents of some compounds (Li et al, ). Modern phytochemical studies have suggested that the major bioactive components of PAR are monoterpene glycosides (e.g.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation